newsfilter
← Latest News
GlobeNewswire·

Senti Bio Releases Virtual Investor "What This Means" Segment

Kanya Rajangam, MD, PhD, President, Head of R&D and Chief Medical Officer of Senti Bio discusses the positive data from lead program, SENTI-202, recently presented at the American Association for Cancer Research